Application of aspirin in treatment of cognitive and behavioral disorders after epilepsy
A technology of aspirin and behavior, applied in the field of medicine, can solve problems such as cognitive impairment of patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0011] 1 Materials and methods
[0012] 1.1 Experimental animals and grouping
[0013] Adult healthy clean male SD rats, weighing about 200-250g, were raised in a light and dark environment for 12h-12h (8:00-20:00), free to drink water, and given a standard diet. All animal experiments were handled in strict accordance with the Guidelines for the Care and Use of Laboratory Animals formulated by the National Institutes of Health. Rats were randomly divided into normal control group, model group and aspirin (20 mg / kg, i.p. 1 / d) intervention group. Dosing was started 14 days after the establishment of the model and continued for 28 days.
[0014] 1.2 Experimental materials
[0015] Lithium chloride (Sigma-Aldrich)
[0016] pilocarpine (Sigma-Aldrich)
[0017] aspirin (Sigma-Aldrich)
[0018] Bromomethylscopolamine (Sigma-Aldrich)
[0019] Diazepam injection (Xi'an Lijun Jingjing Pharmaceutical Co., Ltd.)
[0020] 1.3 Establishment of epilepsy model in rats induced by lith...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com